Td Asset Management Inc Glaukos Corp Transaction History

Td Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$59.53 - $85.11 $2.29 Million - $3.27 Million	38,448 New	38,448 $3.06 Million
Q3 2018 Nov 01, 2018	SELL	$38.13 - $68.37 $1.06 Million - $1.91 Million	-27,895 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$27.62 - $44.51 $2,762 - $4,451	100 Added 0.36%	27,895 $1.13 Million
Q1 2018 May 11, 2018	SELL	$26.05 - $34.5 $7,945 - $10,522	-305 Reduced 1.09%	27,795 $857,000
Q4 2017 Feb 02, 2018	BUY	$24.5 - $36.01 $102,900 - $151,242	4,200 Added 17.57%	28,100 $721,000
Q3 2017 Nov 09, 2017	BUY	$31.26 - $42.03 $747,114 - $1 Million	23,900	23,900 $789,000

345

46.7M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.63B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.